INSIGHTS ON QUALITY ASSURANCE
-
What Pharmacies Often Miss In USP <800> Compliance
Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.
-
Design Testing Strategies To Develop A Drug-Device Combination Product
Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.
-
How Do You Navigate GxP Compliance?
Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.
-
Improved High-Speed Performance X-Ray
Maintain uncompromised inspection clarity at maximum operational speeds. Learn how a specialized sensor captures distortion-free imaging at 80 meters per minute.
-
Unifying EAM And ERP: Transform Asset Management In Life Sciences3/23/2026
Fragmented systems create compliance risks and operational inefficiencies. Learn how integrated asset management and ERP platforms eliminate duplicate work while maintaining audit-ready documentation.
-
How To Use Enzyme Indicators In An Aseptic Production Environment6/30/2026
Discover how transitioning to quantitative validation data allows engineering teams to optimize decontamination timelines, slash system downtime, and minimize product carryover risks.
-
A Simple Method For Cell Growth Media Preparation11/3/2025
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Digital Transformation And Quality By Design For Enhanced Development7/23/2025
Discover how digital transformation and Quality by Design are revolutionizing pharmaceutical development to boost efficiency, enhance compliance, and accelerate innovation across the drug lifecycle.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return1/29/2026
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
QUALITY ASSURANCE SOLUTIONS
-
Residual CD3+ cells shouldn't be the bottleneck in your allogeneic therapy workflow. This prototype achieves <0.5% residual T cells at commercial-scale processing capacity.
-
Streamline your facility lifecycle with a unified validation framework designed to maximize process control, reduce downtime, and meet stringent sterility compliance.
-
Safe HPAPI handling takes more than containment alone. Strong operator protection, leak and glove testing, modular workflow flexibility, and cleaning features all come together to support safer processing.
-
The XR75 Pharma X-ray is optimized for the quality control of pharmaceutical, nutraceutical, and cosmetic products in thin opaque packaging materials that cannot be inspected manually or with visual systems. The leakage prevention curtains are designed to leave a 10 mm-clearance that ensures safety and reduces false rejects caused by product jams or changed orientation during conveyance. The system checks for different product integrity issues simultaneously: products trapped in seals, missing, chipped, or broken tablets in blisters, and the presence of foreign contaminants. The high-resolution X-ray images ensure reliable inspection of the small items at belt speed up to 90 m/min.
-
CAI’s Kneat: Data Ready provides you with best-in-class content and templates created by industry-leaders, giving you a headstart in implementing your own Kneat solution.
Kneat: Data Ready offers not only templates, but a validated out-of-the-box configuration that you can tailor to your business needs. Implement your Kneat instance in less than half the time.